BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 29102562)

  • 1. Prostaglandin E
    Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
    Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
    Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
    Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
    Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
    Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.
    Greene MR; Lockey T; Mehta PK; Kim YS; Eldridge PW; Gray JT; Sorrentino BP
    Hum Gene Ther Methods; 2012 Oct; 23(5):297-308. PubMed ID: 23075105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.
    Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB
    Stem Cells; 2015 May; 33(5):1532-42. PubMed ID: 25588820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia.
    Zhao HF; Abraham A; Kim YS; Wang YD; Pestina T; Zhan J; Humphries K; Nienhuis AW; Persons DA
    Mol Ther; 2017 Mar; 25(3):593-605. PubMed ID: 28190779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis
    Drakopoulou E; Georgomanoli M; Lederer CW; Kleanthous M; Costa C; Bernadin O; Cosset FL; Voskaridou E; Verhoeyen E; Papanikolaou E; Anagnou NP
    Hum Gene Ther; 2019 May; 30(5):601-617. PubMed ID: 30324804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
    Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
    Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
    Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
    Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
    Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
    Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells.
    Moreau T; Bardin F; Imbert J; Chabannon C; Tonnelle C
    Mol Ther; 2004 Jul; 10(1):45-56. PubMed ID: 15233941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
    Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
    Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene delivery to hematopoietic stem cells using lentiviral vectors.
    Miyoshi H
    Methods Mol Biol; 2004; 246():429-38. PubMed ID: 14970608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant
    Petrillo C; Calabria A; Piras F; Capotondo A; Spinozzi G; Cuccovillo I; Benedicenti F; Naldini L; Montini E; Biffi A; Gentner B; Kajaste-Rudnitski A
    Hum Gene Ther; 2019 Sep; 30(9):1133-1146. PubMed ID: 31037976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cells.
    Papanikolaou E; Georgomanoli M; Stamateris E; Panetsos F; Karagiorga M; Tsaftaridis P; Graphakos S; Anagnou NP
    Hum Gene Ther; 2012 Jan; 23(1):15-31. PubMed ID: 21875313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
    Bahner I; Sumiyoshi T; Kagoda M; Swartout R; Peterson D; Pepper K; Dorey F; Reiser J; Kohn DB
    Mol Ther; 2007 Jan; 15(1):76-85. PubMed ID: 17164778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancers.
    Ingrao D; Majdoul S; Seye AK; Galy A; Fenard D
    Hum Gene Ther Methods; 2014 Feb; 25(1):48-56. PubMed ID: 24152219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.
    Negre O; Bartholomae C; Beuzard Y; Cavazzana M; Christiansen L; Courne C; Deichmann A; Denaro M; de Dreuzy E; Finer M; Fronza R; Gillet-Legrand B; Joubert C; Kutner R; Leboulch P; Maouche L; Paulard A; Pierciey FJ; Rothe M; Ryu B; Schmidt M; von Kalle C; Payen E; Veres G
    Curr Gene Ther; 2015; 15(1):64-81. PubMed ID: 25429463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.